Syntheses of 2-amino-4-hydroxy-6-hydroxymethylpteridine-10-C14 and 2-amino-4-hydroxypteridine-10-C14 and their metabolism in Drosophila melanogaster

Alterations in dihydropteroate synthetase in cell-free extracts of sulfanilamide-resistant Neisseria meningitidis and Neisseria gonorrhoeae

Extracts from Neisseria meningitidis and N. gonorrhoeae with varying susceptibility to sulfanilamide have been investigated for dihydropteroate synthetase activity. Sulfanilamide was a competitive inhibitor of dihydropteroate synthetase with respect to p-aminobenzoate in extracts from both species. Though the K(m) for p-aminobenzoate was unaffected, the K(i) for sulfanilamide increased and the V(max) decreased as the strains' resistance to sulfanilamide increased. Temperature studies have revealed differences in the dihydropteroate synthetase from N. meningitidis and N. gonorrhoeae. A direct relationship was observed between the minimal inhibitory concentration of sulfanilamide determined in vitro and the ratio of K(i)/K(m). This ratio may be a molecular explanation of sulfanilamide resistance for both N. meningitidis and N. gonorrhoeae.

Anaerobic degradation of pteridines and purines by intestinal organisms

Microorganisms located within rat cecal contents degraded or catabolized [2-14C]pteridines and [2-14C]purines under anaerobic conditions, resulting in the release of 14CO2. A saturating concentration of guanosine did not affect the rate of release of CO2 from biopterin, and, likewise, the presence of a saturating level of biopterin did not significantly alter the release of CO2 from guanosine, indicating that the catabolism of these two compounds was by different systems. Part of the catabolic organisms for guanosine were segregated in a culture dilution experiment. These catabolic activities were detected in feces of humans and various other mammals. The results are compared with previously published data on the degradation of pteridines and purines.

Plasmid-mediated sulfanilamide resistance

Dihydropteroate synthetase (DHPS) is specified by a substrain of Escherichia coli K12, ML1410. This enzyme activity is inhibited by sulfanilamides (Sa) and is known to be heat-stable, i.e., an Sa-sensitive normal enzyme. Another DHPS activity specified by E. coli ML1410 carrying drug resistance plasmids is Sa-resistant but heat-sensitive, i.e., an Sa-resistant enzyme. Most plasmids encoding single Sa or double (Sa. Tc or Sa. Sm) (Tc, tetracycline; Sm, streptomycin) resistance mediate the formation of this type of DHPS. Therefore, E. coli carrying these plasmids becomes diploid for DHPS, i.e., an Sa-resistant and an Sa-sensitive normal enzyme. The biochemical mechanism of Sa resistance mediated by plasmids encoding triple (Cm.Sm.Sa; Tc.Sm.Sa) and quadruple (Cm.Tc.Sm.Sa) resistance is not due to the formation of an altered DHPS but probably due to the decrease in permeation of the drug into the cell. The evolutionary process of the formation of Sa-resistance determinants on plasmids is discussed based on the presence of two types of Sa resistance mechanism.